Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Cattles

Immunological veterinary medicinal products, including vaccines, are authorised for cattle.

Search results 26 to 50 from a total of 65

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Aftopur AlSap

Maul- und Klauenseuche

Boehringer Ingelheim Vetmedica GmbH

BFAV-B 366 17.12.2003 Rind, Schaf, Ziege

Decivac FMD DOE

Maul- und Klauenseuche

Intervet Deutschland GmbH

BFAV-MKS/2/2000 31.07.2000 Rind, Schaf, Schwein, Ziege

Startvac

Mastitis (Colibakterien, Staphylokokken)

Laboratorios Hipra S.A., Spanien

EU/2/08/092/001-007 13.02.2009 Rind

EPAR: Startvac

UBAC

Mastitis

Laboratorios Hipra S.A.,Spanien

EU/2/18/227 26.07.2018 Rind

EPAR: UBAC

Spirovac

Leptospiren- Infektion

Zoetis Deutschland GmbH

PEI.V.03608.01.1 29.02.2008 Rind

Bovilis Cryptium

Kryptosporidiose

Intervet International B.V., Netherlands

EU/2/23/303 24.11.2023 Rind

EPAR: Bovilis Cryptium

Zulvac SBV

Infektion mit dem Schmallenbergvirus

Zoetis Belgium S.A., Belgien

EU/2/14/178/001 06.02.2015 Schaf, Rind

EPAR: Zulvac SBV

Bovigrip RSP plus

Enzootische Bronchopneumonie, BRSV-Infektion, Parainfluenza-3, Pasteurellose

Intervet Deutschland GmbH

PEI.V.02900.01.1 20.07.2004 Rind

BOVALTO Respi 3

Enzootische Bronchopneumonie,
BRSV-Infektion, Parainfluenza-3, Pasteurellose

Boehringer Ingelheim Vetmedica GmbH

PEI.V.11801.01.1 01.12.2015 Rind

BOVALTO Respi 4

Enzootische Bronchopneumonie,
BRSV-Infektion, Parainfluenza-3, BVD/MD, Pasteurellose

Boehringer Ingelheim Vetmedica GmbH

PEI.V.11802.01.1 01.12.2015 Rind

HIPRABOVIS SOMNI/Lkt

Enzootische Bronchopneumonie

Laboratorios Hipra S.A., Spanien

PEI.V.03470.01.1 12.02.2007 Rind

Bravoxin

Enterotoxämie, Rauschbrand, Pararauschbrand, Deutsche Bradsot, Gasödem, Tetanus, Infektiöse Hämoglobinurie

Intervet Deutschland GmbH

PEI.V.12037.01.1 03.08.2020 Rind, Schaf

Covexin 8

Enterotoxämie,
Rauschbrand,
Pararauschbrand,
Deutsche Bradsot,
Tetanus,
Infektiöse Hämoglobinurie

Zoetis Deutschland GmbH

A263/79 24.10.2005 Rind, Schaf, Schwein

Covexin Zehn

Enterotoxämie,
Rauschbrand,
Pararauschbrand,
Deutsche Bradsot,
Gasödem,
Tetanus,
Infektiöse Hämoglobinurie

Zoetis Deutschland GmbH

PEI.V.03186.01.1 24.09.2004 Rind, Schaf

Bovilis Nasalgen-C

Coronavirus-Infektion

Intervet International B.V., Netherlands

EU/2/23/294 31.03.2023 Rind

EPAR: Bovilis Nasalgen-C

Mucosiffa

BVD/MD

Ceva Tiergesundheit GmbH

PEI.V.03518.01.1 06.03.2008 Rind

Bovela

BVD/MD

Boehringer Ingelheim Vetmedica GmbH

EU/2/14/176/001-016 22.12.2014 Rind

EPAR: Bovela

BOVALTO Respi Intranasal

BRSV-Infektion, Parainfluenza-3

Boehringer Ingelheim Vetmedica GmbH

PEI.V.11947.01.1 19.03.2018 Rind

Rispoval 2 / BRSV + Pi3

BRSV-Infektion, Bovine Parainfluenza

Zoetis Deutschland GmbH

PEI.V.12018.01.1 18.11.2020 Rind

Bovilis IntraNasal RSP Live

BRSV-Infektion, Bovine Parainfluenza

Intervet Deutschland GmbH

PEI.V.11976.01.1 18.05.2019 Rind

Rispoval 3-BRSV-PI3-BVD

BRSV-Infektion,
Parainfluenza-3,
BVD/MD

Zoetis Deutschland GmbH

PEI.V.03128.01.1 21.04.2005 Rind

Rispoval RS+PI3 IntraNasal

BRSV-Infektion,
Parainfluenza-3

Zoetis Deutschland GmbH

PEI.V.03416.01.1 15.08.2006 Rind

Rispoval RS

BRSV-Infektion

Zoetis Deutschland GmbH

116a/89 28.10.2005 Rind

NASYM

BRSV-Infektion

Laboratorios Hipra S.A., Spanien

EU/2/19/241 29.07.2019 Rind

DIVENCE IBR Marker Live

Bovines Herpesvirus

Laboratorios Hipra, S.A., Spanien

EU/2/24/318 20.08.2024 Rind

EPAR: DIVENCE IBR Marker Live

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 530 in BAnz AT 16.06.2025 B4.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 17.06.2025